Stable Isotope Labeled Compound Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Stable Isotope Labeled Compound Market is segmented By Type (Deuterium, Carbon 12 and Carbon 13, Oxygen 16 and Oxygen 18, Nitrogen 15, Lithium 6 and Lithium 7, Chlorine 35 and Chlorine 37, Sulphur 34, Others), By Application (Research, Industrial, Clinical Diagnostics, Others), By End-User (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Centers, Academic & Research Institutes, Others), and By Region (North America, South America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Stable Isotope Labeled Compound Market Overview

180 pages report analyses the Global Stable Isotope Labeled Compound Market size, shares, recent trends, competitive intelligence, and future market outlook. Demand from Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Centers, Research Institutes in North America is rising. Competitive rivalry intensifies with Perkinelmer, IsoSciences LLC, Huayi Isotopes Co and others operating in the market.

Stable isotope-labelled compounds are non-reactive chemical substances where one or more than one element within a compound is substituted for its stable isotopes. The stable isotope-labelled products serve as a useful tool in the study of dynamic metabolomics and steady-state. These compounds show ideal properties for studying metabolic flux, as they precisely mimic endogenous natural abundance metabolites. Their significant role in assessing in vivo metabolism in a vast range of metabolic research has built a massive market for the research sector.

Stable isotopes are often paired with mass spectrometry or nuclear magnetic resonance to give dynamic information regarding turnover rate and physiological regulation. The coupling of the technologies mentioned above with stables isotopes has enabled researchers to better utilize stable isotope-labelled compounds for evaluating drug disposition and their toxicity profiling before using it on the patient population.

Apart from gaining popularity in the research sector, stable labelled isotopes play a vital role in managing several diseases such as cancer and diabetes. Pharmaceutical research, biomedical research, environmental & ecological research, industrial and agricultural research are among the other most promising sectors for stable isotope-labelled compound application.

Stable Isotope Labeled Compound Market Scope

For More Insights Download Sample

Stable Isotope Labeled Compound Market Dynamics and Trends

The global stable isotope-labelled compound is driven by increasing research activities in biotechnology, pharmaceutical, agricultural, biomedical sectors, coupled with rising proteomics research. The rising prevalence of various types of cancer worldwide is one of the key factors accelerating the market of stable isotope-labelled compounds in recent times. Ongoing studies on various drug toxicity to develop the most effective therapeutic and diagnostic techniques have raised the stable isotope-labelled compound's demand volume.

Increasing research activities in biotechnology, pharmaceutical, agricultural, biomedical sectors, coupled with rising proteomics research

The stable isotope-labelled compound has gained a tremendous market in the field of biomedical research. Combining stable isotope-labelled techniques with mass spectroscopy allows rapid acquisition and interpretation of data, promoting stable isotope-labelled compounds in various fields such as absorption and distribution and metabolism excretion studies. Apart from this, the use of stable isotope-labelled compounds in various aspects of metabolism and pharmacokinetics of drugs and other foreign compounds in humans and animals is expected to boost the stable isotope-labelled compound during the forecast period.

Compound labelled with carbon-13 and deuterium has been useful in the past by the drug metabolism scientists and toxicologists to understand different drug disposition and their potential role in target organ toxicities. For instance, in 2014, PerkinElmer came up with a Syngistix and NexION atomic spectroscopy software platform solution. The product is designed to target trace metals or elements in drinking water, impurities in pharmaceuticals, and adulterants in food.

Rising prevalence of various types of cancer across the world

As per WHO 2018, cancer is the second leading cause of death worldwide, and till 2018 it is responsible for taking 9.6 million lives. Nearly 70% of deaths due to cancer occur in low and middle-income countries. Currently, the most common types of cancers are- lung cancer (2.09 million), breast cancer (2.09 million), colorectal cancer (1.80 million), prostate (1.28 million), skin cancer (non-melanoma) (1.04 million), and stomach cancer (1.03 million). Stable isotope-labelled compounds are an essential technology used to study the molecular mechanisms by which nutraceuticals modulate and target cancer metabolism.

The compounds are used as exogenous nutrients and monitor their downstream metabolites labelling patterns, thus enabling the analysis of specific metabolic pathway activity via the relative production and consumption of the labelled metabolites. A growing number of cancer patients and rising cancer investigations are expected to build a massive market of stable isotope-labelled compounds in the forecast period. However, various studies are going on bioactive compounds' molecular activity and designing synergistic nutraceutical combinations that are still underutilized.

The growing use of stable isotopes in clinical diagnosis and research in the pediatric population creates a broad spectrum of opportunities for the market to grow in coming tenures

The stable isotope-labelled compounds are nonreactive, and nearly 6000 stable isotope-labelled compounds are commercially available for metabolic studies. As per various studies, it is currently accepted that these compounds show negligible biological side effects, which allows them to be used for pediatric treatment ethically. As compared to radioactive isotopes, stable isotopes labelled compounds show various advantages and can be safely administrated simultaneously to the same subject without compromising future studies.

The plasma volume from one sample required to analyze the isotope enrichment is small, allowing even preterm infants to be studied. These tracers are safe and may be particularly important for validating new treatment modalities such as gene therapy or novel drug treatments; thus, the growing demand for diagnostics and treatment from stable isotope-labelled compounds in the pediatric population is creating tremendous opportunities for the market to proliferate in the coming years.

COVID-19 Impact Analysis on Stable Isotope Labeled Compound Market

The global outbreak of coronavirus has disrupted the entire lifestyle of the human system. Apart from losing lives daily due to COVID-19, many companies lost their business during the lockdown period. Due to COVID-19, a significant drop is seen in inpatient visits to the hospitals due to temporary lockdown and constraints implemented to prevent the disease from spreading in not-affected zones.

Apart from this, various research institutes have put their regular studies targeting stable isotope-labelled compounds due to ongoing research on COVID-19 treatment and diagnosis. Thus this sudden research shit and drop in cancer-positive patients in the hospital have hampered a massive market of stable isotope-labelled compounds in recent times. The momentum is expected to maintain until the pandemic gets over.

Stable Isotope Labeled Compound Market Segmentation Analysis

The global stable isotope-labelled compounds market is segmented based on types, application end-user and region.

Growing pharmaceutical research using deuterium and improving nuclear study at an affordable cost

The stable isotope-labelled compounds market can be bifurcated into carbon 12 and carbon 13, deuterium, oxygen 16 and oxygen 18, nitrogen-15, lithium 6 and lithium 7, chlorine 35 and chlorine 37, sulphur 34 and others in terms of type. Deuterium dominated the 2019 market of stable isotope-labelled compounds and is expected to maintain the conjecture period's market momentum. This segment's significant growth is due to growing pharmaceutical research using deuterium and improving nuclear study.

Deuterium is mostly used by toxicologists and metabolism scientists to identify the significant role in targeting organ toxicities and drug disposition. The deuterium isotope is the cheapest among all the pre-existing isotopes and is easiest to introduce into any molecule. Therefore, the growing application of deuterium in different healthcare sectors at an affordable cost is triggering its market in recent times.

Global Stable Isotope Labeled Compound Market Geographical Share

Growing pharmaceutical and biopharmaceutical industries in the region and increasing prevalence of cancer patients in North America

North America is expected to dominate the stable isotope-labelled compound market in the forecast period owing to growing pharmaceutical and biopharmaceutical industries in the region. The growing Canadian pharmaceutical industry and rising investments by the government in the U.S.'s nuclear industry trigger the research demand.

Related projects on the stable isotope-labelled compound are adding value to the growing market. As per National Cancer Institute, in 2020, an estimated 1,806,590 new cases have been diagnosed for cancer in the U.S., and nearly 606,520 people are expected to lose their lives. The growing numbers of cancer patients in the region and established infrastructure in the region boost the stable isotope-labelled compound for the past few years.

Stable Isotope Labeled Compound Market Companies

The stable isotope-labelled compound market is highly fragmented with the presence of limited global companies. Some of the key players contributing to the market's growth include Perkinelmer, Cambridge Isotope Laboratories, Inc, Merck KGaA, URENCO Limited, Trace Sciences International, IsoSciences LLC, Omicron Biochemicals, Inc, Huayi Isotopes Co, Alsachim, Taiyo Nippon Sanso Corporation, and among others.

The significant players adopt several growth strategies such as product launches, acquisitions, and collaborations, contributing to the globally stable isotope-labelled compound market. The key players favour acquisition and collaboration as the growth strategy for building revenue for the company.

For instance, in 2018, Taiyo Nippon Sanso Corporation announced its complete acquisition of SAIL technologies Inc, a Japan-based manufacturer and distributor of stable isotope-labelled amino acids. The acquisition will strengthen the products for Taiyo Nippon Sanso Corporation and helped in increasing market share since 2018

Merck KGaA

Overview: Merck KGaA is a research-driven industrial company established in 1827. Emanuel Merck, founder of Merck KGaA, isolated and characterized alkaloids for distribution to chemists. The company also came up with a biotechnology production process and entered the market; currently, it is a global pharmaceutical, chemical, and life-science global leader.

Product Portfolio: The company has a product portfolio of stable isotope-labeled compounds that includes:

• ISOTEC: It is a stable isotope that produces stable isotope products ranging from gases to complex molecules. Products include under ISOTEC are amino acids, bioactive compounds, carbohydrates, and salts- all with isotopic labelling. These products are used for tracing studies in proteomics and metabolomics studies

Key Development

• In November 2015, Merck KGaA acquired Sigma-Aldrich Corporation, and the company secured the second position as the global stable isotope-labelled compound market after this acquisition. This acquisition considerably expanded Merck KGaA geographical footprint especially targeting North America

Why Purchase the Report?

• Visualize the stable isotope-labelled compound market segmentation by types, application end-user and highlight key commercial assets and players.
• Identify commercial opportunities in the stable isotope-labelled compound market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of stable isotope-labelled compound market-level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The global stable isotope-labelled compound market report would provide access to an approx: 61 market data tables, 59 figures, and 180 pages.

Target Audience 2024

• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturers